Sandbox/table: Difference between revisions

Jump to navigation Jump to search
Guillermo Rodriguez Nava (talk | contribs)
Created page with " {| class="wikitable" |+ Countries with a reported prevalence <15% of ''H. pylori'' resistance to clarithromycin ! Europe !! North America !! South America !! Middle East !! ..."
 
GeraldChi (talk | contribs)
No edit summary
Line 1: Line 1:




{| class="wikitable"
{| style="border: 2px solid #DCDCDC; font-size: 90%; width: 80%;"
|+ Countries with a reported prevalence <15% of ''H. pylori'' resistance to clarithromycin
|+ Countries with a reported prevalence <15% of ''H. pylori'' resistance to clarithromycin
! Europe !! North America !! South America !! Middle East !! Far East
! style="background: #DCDCDC;" | Europe  
! style="background: #DCDCDC;" | North America  
! style="background: #DCDCDC;" | South America  
! style="background: #DCDCDC;" | Middle East  
! style="background: #DCDCDC;" | Far East
|-
|-
| Bulgaria (8.7%) || USA (10.6-12.2%) || Brazil (9.8%) || Israel (8.2%) || Hong Kong (4.5)
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top |
|-
* Bulgaria (8.7%)  
| Croatia (8%) || cell || cell || cell || Japan (11-12.9)
* Croatia (8%)
|-
* Germany (2.2–4%)
| Germany (2.2-4%) || cell || cell || cell || Korea (5.4-5.9%)
* Italy (North) (1.8%)
 
* Netherlands (1.7%)
|-
* Spain (12.9%)
| Italy (North) (1.8%) || cell || cell || cell || New Zealand (6.8)
* Sweden (2.9%)
 
* UK (3.9–4.4%)
|-
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top |
| Netherlands (1.7%) || cell || cell || cell || cell
* USA (10.6–12.2%)
|-
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top |
| Spain (12.9%) || cell || cell || cell || cell
* Brazil (9.8%)
|-
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top |
| Sweden (2.9%) || cell || cell || cell || cell
* Israel (8.2%)
|-
| style="background: #F5F5F5; padding: 0 10px; width: 20%;" valign=top |
| UK (3.9-4.4%) || cell || cell || cell || cell
* Hong Kong (4.5%)
* Japan (11–12.9%)
* Korea (5.4–5.9%)
* New Zealand (6.8%)
|}
|}

Revision as of 19:52, 4 June 2014


Countries with a reported prevalence <15% of H. pylori resistance to clarithromycin
Europe North America South America Middle East Far East
  • Bulgaria (8.7%)
  • Croatia (8%)
  • Germany (2.2–4%)
  • Italy (North) (1.8%)
  • Netherlands (1.7%)
  • Spain (12.9%)
  • Sweden (2.9%)
  • UK (3.9–4.4%)
  • USA (10.6–12.2%)
  • Brazil (9.8%)
  • Israel (8.2%)
  • Hong Kong (4.5%)
  • Japan (11–12.9%)
  • Korea (5.4–5.9%)
  • New Zealand (6.8%)